Melanoma, Malignant Completed Phase 4 Trials for Vemurafenib (DB08881)

Also known as: Malignant Melanoma / [M]Malignant melanoma NOS / Melanoma / Melanoma malignant

IndicationStatusPhase
DBCOND0107071 (Melanoma, Malignant)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01898585An Open-Label Study of Zelboraf (Vemurafenib) in Patients With Braf V600 Mutation Positive Metastatic MelanomaTreatment